Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience

Van der Merwe NC, Combrink HM, Ntaita KS, Oosthuizen J. Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience. Front Genet. 2022;13:834265. https://pubmed.ncbi.nlm.nih.gov/35464868/

By Peter Matlawa|2023-04-18T15:59:06+02:00April 18, 2023|2022: April to June|Comments Off

About the Author: Peter Matlawa